Research graph
References from Multi-context modeling of driver pathways reveals common and specific mechanisms across 23 cancer types. Local targets link to admitted publications; unresolved targets remain external evidence.
The Wnt signalling pathway: a tailored target in cancer
10.3390/ijms21207697 · 2020 · External reference
Genomics, signaling, and treatment of Waldenström macroglobulinemia
10.1200/jco.2016.71.0814 · 2017 · External reference
Comprehensive molecular portraits of human breast tumours
10.1038/nature11412 · 2012 · External reference
Pan-cancer analysis of whole genomes
10.1038/s41586-020-1969-6 · 2020 · External reference
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data
10.1158/2159-8290.cd-12-0095 · 2012 · External reference
The causes and consequences of genetic heterogeneity in cancer evolution
10.1038/nature12625 · 2013 · External reference
An analysis of genetic heterogeneity in untreated cancers
10.1038/s41568-019-0185-x · 2019 · External reference
Cancer genome landscapes
10.1126/science.1235122 · 2013 · External reference
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes
10.1038/ng.3168 · 2015 · External reference
Mutual exclusivity analysis identifies oncogenic network modules
10.1101/gr.125567.111 · 2012 · External reference
De novo discovery of mutated driver pathways in cancer
10.1101/gr.120477.111 · 2012 · External reference
Efficient methods for identifying mutated driver pathways in cancer
10.1093/bioinformatics/bts564 · 2012 · External reference
Discovery of cancer common and specific driver gene sets
10.1093/nar/gkx089 · 2017 · External reference
Pan-cancer study on transition of signaling systems from primary to metastatic tumors
2024 · External reference
A compendium of mutational cancer driver genes
10.1038/s41568-020-0290-x · 2020 · External reference
Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer
10.3389/fgene.2022.916400 · 2022 · External reference
10.1109/bibm47256.2019.8983414
10.1109/bibm47256.2019.8983414 · External reference
Two novel models and a parthenogenetic algorithm for detecting common driver pathways from pan-cancer data
10.1016/j.engappai.2020.104010 · 2020 · External reference
ROS signalling in the biology of cancer
10.1016/j.semcdb.2017.05.023 · 2018 · External reference
Targeting IGF-1 signaling pathways in gynecologic malignancies
10.1517/14728222.2013.749863 · 2013 · External reference
Adoptive cell therapy in breast cancer: a current perspective of next-generation medicine
10.3389/fonc.2020.605633 · 2020 · External reference
Giant cell tumor of soft tissue of the breast: case report with H3F3A mutation analysis and review of the literature
10.1016/j.prp.2019.152750 · 2020 · External reference
Comprehensive epigenetic analyses reveal master regulators driving lung metastasis of breast cancer
10.1111/jcmm.14424 · 2019 · External reference
Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression
10.1186/bcr2924 · 2011 · External reference
HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
10.1080/10408363.2019.1653821 · 2019 · External reference
Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma
10.1038/modpathol.2017.33 · 2017 · External reference
Deregulated bone morphogenetic proteins and their receptors are associated with disease progression of gastric cancer
10.1016/j.csbj.2019.12.014 · 2020 · External reference
miR-148a regulates the stem cell-like side populations distribution by affecting the expression of ACVR1 in esophageal squamous cell carcinoma
10.2147/ott.s248925 · 2020 · External reference
Abandoning the notion of non-small cell lung cancer
10.1016/j.molmed.2019.04.012 · 2019 · External reference
Targeting PKCL-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma
10.1186/s12964-019-0446-z · 2019 · External reference
Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer
10.1007/s10719-018-9815-x · 2018 · External reference
Network pharmacology and experimental evidence reveal dioscin suppresses proliferation, invasion, and EMT via AKT/GSK3b/mTOR signaling in lung adenocarcinoma
10.2147/dddt.s249651 · 2020 · External reference
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition
2023 · External reference
Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
10.1016/j.jtho.2022.09.225 · 2023 · External reference
Sex differences in cancer mechanisms
10.1186/s13293-020-00291-x · 2020 · External reference
Common risk factors of breast and ovarian cancer: recent view
10.1136/ijgc-00009577-200409000-00002 · 2004 · External reference
The role of ACKR3 in breast, lung, and brain cancer
10.1124/mol.118.115279 · 2019 · External reference
GNAi2/gip2-regulated transcriptome and its therapeutic significance in ovarian cancer
10.3390/biom11081211 · 2021 · External reference
EIF1AX and NRAS mutations co-occur and cooperate in low-grade serous ovarian carcinomas
10.1158/0008-5472.can-16-2224 · 2017 · External reference
Transcriptional repression of p21 by EIF1AX promotes the proliferation of breast cancer cells
2020 · External reference
FGFR3 signaling and function in triple negative breast cancer
10.1186/s12964-019-0486-4 · 2020 · External reference
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
10.1038/s41467-020-16199-4 · 2020 · External reference
The prognostic value of the lysyl oxidase family in ovarian cancer
2020 · External reference
GATA3 in breast cancer: tumor suppressor or oncogene?
10.3727/105221615x14399878166113 · 2015 · External reference
GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma
10.1016/j.cellsig.2020.109539 · 2020 · External reference
Rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance
10.1007/s12282-020-01091-2 · 2020 · External reference
Ovarian tumor microenvironment signaling: convergence on the Rac1 GTPase
10.3390/cancers10100358 · 2018 · External reference
CD4+ follicular helper T cell infiltration predicts breast cancer survival
10.1172/jci67428 · 2013 · External reference
Cordyceps militaris induces apoptosis in ovarian cancer cells through TNF-α/TNFR1-mediated inhibition of NF-κB phosphorylation
10.1186/s12906-019-2780-5 · 2020 · External reference
Case report of spontaneous resolution of a congenital glioblastoma
10.1542/peds.2015-1241 · 2016 · External reference
Targeting acute myeloid leukemia stem cell signaling by natural products
10.1186/s12943-016-0571-x · 2017 · External reference
Aberrant cytokine signaling in leukemia
10.1038/sj.onc.1210758 · 2007 · External reference
Fibroblast growth factor receptor functions in glioblastoma
10.3390/cells8070715 · 2019 · External reference
Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer
10.1124/pr.114.009217 · 2014 · External reference
PHF6 suppresses self-renewal of leukemic stem cells in AML
10.1038/s41375-024-02340-5 · 2024 · External reference
ASXL1 gene in AML
2021 · External reference
The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells
10.3390/ijms21082907 · 2020 · External reference
Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML
10.1038/s41598-021-91864-2 · 2021 · External reference
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
10.18632/oncotarget.7961 · 2016 · External reference
Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma
10.1158/0008-5472.can-08-3272 · 2008 · External reference
Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia
10.3324/haematol.2020.269431 · 2022 · External reference
Genetic aberrations involved in relapse of pediatric acute myeloid leukemia: a literature review
10.1111/ajco.13367 · 2021 · External reference
Acute leukemia in adolescents and young adults
10.1053/j.seminoncol.2009.03.007 · 2009 · External reference
RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia
10.1038/s41375-018-0102-4 · 2018 · External reference
Long noncoding RNAs: emerging players in medulloblastoma
10.3389/fped.2019.00067 · 2019 · External reference
Uncommon pediatric tumors of the posterior fossa: pathologic and molecular features
10.1007/s00381-015-2735-1 · 2015 · External reference
Origin and initiation mechanisms of neuroblastoma
10.1007/s00441-018-2796-z · 2018 · External reference
EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma
10.1002/mc.23176 · 2020 · External reference
Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells
10.1042/bsr20200723 · 2020 · External reference
Smoking-related cancer death among men and women in an ageing society (China 2020-2040): a population-based modelling study
10.1136/tobaccocontrol-2020-056444 · 2023 · External reference
Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence
10.1038/s41588-021-00928-6 · 2021 · External reference
Tracking the evolution of non-small-cell lung cancer
10.1056/nejmoa1616288 · 2017 · External reference
Exploring potential biomarkers for lung adenocarcinoma using LC-MS/MS metabolomics
10.1177/0300060519897215 · 2020 · External reference
Genomic and evolutionary classification of lung cancer in never smokers
10.1038/s41588-021-00920-0 · 2021 · External reference
Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling
10.1074/jbc.ra120.015352 · 2021 · External reference
Tobacco smoking-associated alterations in the immune microenvironment of squamous cell carcinomas
10.1093/jnci/djy060 · 2018 · External reference
Insights into nanomedicine for head, neck cancer diagnosis and treatment
10.3390/ma15062086 · 2086 · External reference
CCTs as new biomarkers for the prognosis of head and neck squamous cancer
10.1515/med-2020-0114 · 2020 · External reference
Profilin 2 promotes proliferation and metastasis of head and neck cancer cells by regulating PI3K/AKT/β-catenin signaling pathway
10.3727/096504019x15579146061957 · 2019 · External reference
Alcohol-related head and neck cancer: summary of the literature
10.1002/hed.26023 · 2020 · External reference
Presynaptic ethanol actions: potential roles in ethanol seeking
10.1007/164_2017_76 · 2018 · External reference
Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis
10.1016/j.ajpath.2010.10.027 · 2011 · External reference
Body Fatness and Cancer–Viewpoint of the IARC Working Group
10.1056/nejmsr1606602 · 2016 · External reference
Obesity and cancer risk: evidence, mechanisms, and recommendations
10.1111/j.1749-6632.2012.06750.x · 2012 · External reference
Chronic viral hepatitis and its association with liver cancer
10.1515/hsz-2017-0118 · 2017 · External reference
Yersinia enterocolitica infection in a patient with hemachromatosis masquerading as proximal colon cancer with liver metastases: report of a case
10.1007/s10350-004-0777-7 · 2005 · External reference
DAVID: a web server for functional enrichment analysis and functional annotation of gene lists 2021 update
2022 · External reference
